
Dr. Osman on Identifying and Treating High-Risk MDS
On “The HemOnc Pulse,” Chadi Nabhan, MD, MBA, FACP, met with Afaf Osman, MD, an Assistant Professor at the University of Utah Huntsman Cancer Center, to discuss how high-risk myelodysplastic syndromes (MDS) are distinct from lower-risk classifications and how to approach treatment.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.